Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Stigma among HIV-positive women complex and overlapping

In this week's PLoS Medicine, Mona Loutfy of the University of Toronto, Canada and colleagues report their study examining experiences of stigma and coping strategies among HIV-positive women in Ontario, Canada.

HIV & AIDS

HIV study identifies key cellular defence mechanism

(Medical Xpress) -- Scientists have moved a step closer to understanding how one of our body’s own proteins helps stop the human immunodeficiency virus (HIV-1) in its tracks.

HIV & AIDS

Neutralizing HIV function

(Medical Xpress) -- Northeastern researchers have played a key role in studying how antibodies that neutralize HIV function are structured, a further step in ongoing global efforts by scientists to develop a vaccine for the ...

HIV & AIDS

Preventing HIV/AIDS one SMS at a time

One million people in Uganda live with HIV/AIDS, where long distances and expensive travel costs significantly limit access to treatment. By employing an innovative mobile-technology strategy, Dr. Femida Gwadry-Sridhar, Director ...

HIV & AIDS

Biologists create anti-HIV antibody that shows increased potency

Using highly potent antibodies isolated from HIV-positive people, researchers have recently begun to identify ways to broadly neutralize the many possible subtypes of HIV. Now, a team led by biologists at the California Institute ...

HIV & AIDS

Standard definition of loss-to-follow-up for ART patients

A study led by Benjamin Chi of the University of Alabama, Birmingham, USA and colleagues reports on the development of a standard definition for loss-to-follow-up (LTFU) that can be used by HIV antiretroviral programs worldwide. ...

HIV & AIDS

Monitoring how T cells respond to HIV

One of the obstacles to developing an effective AIDS vaccine is the difficulty in measuring how well a potential vaccine primes the body to defend itself against HIV.

HIV & AIDS

Study: Gates project spared 100K Indians from HIV

(AP) -- An estimated 100,000 people in India may have escaped HIV infection over five years thanks to one of the world's biggest prevention programs, an encouraging sign that targeting high-risk groups remains vital even ...